126 related articles for article (PubMed ID: 2974196)
1. Kidney graft survival and immunologic changes in patients conditioned with donor-specific transfusions prior to transplantation.
Bean MA; Mickelson E; Yanagida J; Ishioka S; Hansen JA
Transplant Proc; 1988 Dec; 20(6):1084-6. PubMed ID: 2974196
[No Abstract] [Full Text] [Related]
2. Effect of pretransplant donor-specific transfusions in renal transplantation.
Leivestad T; Flatmark A; Hirschberg H; Thorsby E
Transplant Proc; 1982 Jun; 14(2):370-3. PubMed ID: 6214064
[No Abstract] [Full Text] [Related]
3. Effect of donor-specific transfusions on renal transplantation in children.
Potter D; Garovoy M; Hopper S; Terasaki P; Salvatierra O
Pediatrics; 1985 Sep; 76(3):402-5. PubMed ID: 3162150
[TBL] [Abstract][Full Text] [Related]
4. Role of donor specific blood transfusions in prolongation of kidney graft survival.
Matsumoto T; Sakagami K; Orita K
Transplant Proc; 1987 Feb; 19(1 Pt 3):2264-7. PubMed ID: 2950636
[No Abstract] [Full Text] [Related]
5. Donor-specific blood transfusions (DST): clinical outcome and immunologic considerations.
Fujiwara T; Sakagami K; Haisa M; Kusaka S; Uda M; Kobayashi N; Tanakaya K; Saito S; Matsuno T; Matsuoka J
Transplant Proc; 1992 Aug; 24(4):1427-8. PubMed ID: 1386699
[No Abstract] [Full Text] [Related]
6. The effect of donor-specific blood transfusion on in vitro alloreactive precursor cell frequencies.
Duffy B; Tyler J; Anderson C; Hanto D; Flye W; Rodey G
Transplant Proc; 1987 Feb; 19(1 Pt 1):753-4. PubMed ID: 2978930
[No Abstract] [Full Text] [Related]
7. Influence of blood transfusions on immune responsiveness.
Kerman RH; Van Buren CT; Payne W; Flechner S; Agostino G; Conley S; Brewer E; Kahan BD
Transplant Proc; 1982 Jun; 14(2):335-7. PubMed ID: 6214061
[No Abstract] [Full Text] [Related]
8. Anti-idiotypic antibodies and suppressor cells in patients receiving pretransplant donor-specific blood transfusions.
Singal DP; Joseph S; Ali M; Blajchman MA; Smith EK; Ludwin D
Transplant Proc; 1987 Aug; 19(4):3399-401. PubMed ID: 2956740
[No Abstract] [Full Text] [Related]
9. Modification of kidney graft survival in dog and man by pre-operative transfusion to the donor.
Jeekel J; Van der Linden CJ; Vegt PA; Buurman WA; Harder F; Persijn G
Proc Eur Dial Transplant Assoc; 1980; 17():457-61. PubMed ID: 7017690
[TBL] [Abstract][Full Text] [Related]
10. Optimization of donor specific blood transfusion in kidney transplantation.
Cheigh JS; Suthanthiran M; Stubenbord WT; Fotino M; Riggio RR; Schechter N; Stenzel KH; Rubin AL
Transplant Proc; 1987 Feb; 19(1 Pt 3):2250-1. PubMed ID: 2978891
[TBL] [Abstract][Full Text] [Related]
11. [Immunological analysis of mixed lymphocyte culture reaction inhibitory factor induced by donor specific blood transfusions in potential kidney transplant patients].
Takeuchi H
Nihon Geka Gakkai Zasshi; 1985 Mar; 86(3):339-49. PubMed ID: 3157045
[TBL] [Abstract][Full Text] [Related]
12. Pretransplant blood transfusions and kidney allograft survival. A clinical and immunological study.
Fehrman I
Scand J Urol Nephrol Suppl; 1981; 65():1-46. PubMed ID: 6217543
[No Abstract] [Full Text] [Related]
13. Donor-specific transfusion (DST) with intermittent administration of azathioprine induces suppressor T cells and MLR-inhibiting factors without sensitization.
Haisa M; Sakagami K; Matsumoto T; Kawamura T; Uchida S; Fujiwara T; Shiozaki S; Inagaki M; Orita K
Transplant Proc; 1989 Feb; 21(1 Pt 2):1814-7. PubMed ID: 2523594
[No Abstract] [Full Text] [Related]
14. Three year experience of donor specific transfusion and concomitant cyclosporine A.
Hillis AN; Duguid J; Evans CM; Bone JM; Sells RA
Transplant Proc; 1987 Feb; 19(1 Pt 3):2248-9. PubMed ID: 2978890
[No Abstract] [Full Text] [Related]
15. Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation.
Bakran A; Taylor GM; Read I; Fergusson W; Johnson RW
Transplant Proc; 1987 Feb; 19(1 Pt 1):748-9. PubMed ID: 2978929
[No Abstract] [Full Text] [Related]
16. Blood transfusion induced calcium unresponsiveness and graft outcome in renal transplantation.
Toma H; Yasuo M; Tanabe K; Takahashi K; Ota K
Transplant Proc; 1991 Feb; 23(1 Pt 2):1340-1. PubMed ID: 1824897
[No Abstract] [Full Text] [Related]
17. Kinetics of antidonor mixed lymphocyte culture responses in donor specific transfusions plus azathioprine-treated patients.
Burlingham WJ; Grailer A; Sparks-Mackety EM; Sondel PM; Sollinger HW
Transplant Proc; 1987 Feb; 19(1 Pt 3):2255-7. PubMed ID: 2978892
[No Abstract] [Full Text] [Related]
18. Characterization of transfusion-induced suppressor cells in prospective kidney allograft recipients.
Lenhard V; Massen G; Seifert P; Johannsen R; Grosse-Wilde H
Transplant Proc; 1982 Jun; 14(2):329-32. PubMed ID: 6214060
[No Abstract] [Full Text] [Related]
19. Anti-idiotypic autoantibodies after donor-specific blood transfusions.
Toma H; Hayasaka Y; Yasuo M; Takahashi K; Teraoka S; Ota K
Transplant Proc; 1987 Feb; 19(1 Pt 1):755-7. PubMed ID: 3274864
[No Abstract] [Full Text] [Related]
20. Priming of cytotoxic T lymphocyte precursors by donor-specific transfusions and modulation post transplant in relation to steroid withdrawal.
Burlingham WJ; Grailer A; Sollinger HW
Transplant Proc; 1988 Dec; 20(6):1166-8. PubMed ID: 3264427
[No Abstract] [Full Text] [Related]
[Next] [New Search]
